Please login to the form below
Video: Immuno-oncology therapies
Immuno-oncology therapies which harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. However, these therapies come with a very high price tag and currently only a few of these drugs have actually reached the market including Opdivo, Keytruda and Yervoy. In this video Director Sue Marett discusses the opportunities and challenges for new immuno-oncology therapies and outlines what these mean for pharma market research.
http://www.researchpartnership.com/news/2016/05/video-immuno-oncology-therapies/
http://www.researchpartnership.com/news/2016/05/video-immuno-oncology-therapies/
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- News
- Medical Technology specialist joins Research Partnership
Research Partnership
- Live webinar
- The power of a good story: Turn your insights into effective storytelling with data visualisation
Research Partnership
- Article
- How will COVID-19 affect uptake of vaccinations against other diseases?
Research Partnership
- Podcast
- Living With Chronic Illness (Series one)
Research Partnership
- Live webinar
- China: How pharma can maximize success in this rapidly changing emerging market
Research Partnership
- Article
- Inhale, Exhale: The struggle of living with Severe Asthma and Severe Eosinophilic Asthma
Research Partnership
